Some of the most prominent names in biotechnology plunged on Thursday as the Nasdaq headed for its worst day in nearly two years.
Read MoreThe latest on the markets
Jim Cramer is disgusted with the tactics taken by this hedge fund activist.
According to Carter Worth of Sterne Agee, shares of Boeing have some serious tailwinds behind them.
Will Black Friday even make a dent at the mall this year? Jim Cramer has a stock up his sleeve that could run ahead of the rest of them.
Headlines after the bell Monday: Amgen, Palo Alto Networks, Workday & more
Get the best of CNBC in your inbox